{"id":"W2591596051","doi":"10.1182/blood.v120.21.1339.1339","title":"Targeting Treatment-Naive CML Stem/Progenitor Cells From Imatinib-Nonresponders with JAK2 (BMS-911543)/ABL Inhibitor Combination Therapy","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cancer research; Imatinib; Imatinib mesylate; Stem cell; Progenitor cell; Tyrosine kinase; Tyrosine-kinase inhibitor; Haematopoiesis; breakpoint cluster region; Medicine; Myeloid leukemia; Immunology; Biology; Internal medicine; Cell biology; Receptor; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001369071,0.000160964,0.0004981143,0.0001727971,0.0001536835,0.00022064,0.0001312665,0.000164638,0.002166488],"category_scores_gemma":[0.00007898371,0.00007307225,0.0001824913,0.000093745,0.00009437888,0.0001132925,0.0001032375,0.0003808574,0.0004470256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001283944,"about_ca_system_score_gemma":0.0001818701,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001704196,"about_ca_topic_score_gemma":0.0005856223,"domain_scores_codex":[0.999967,0.000004656888,0.000003307516,0.000005676998,0.000009840728,0.000009400696],"domain_scores_gemma":[0.9999778,0.00000274919,0.000003724691,0.000002447144,0.000002719725,0.00001056821],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.005727335,0.002544475,0.007709641,0.0002673667,0.0000850569,0.0009155237,0.0001298187,0.001023026,0.8712224,0.0007170221,0.00196956,0.1076888],"study_design_scores_gemma":[0.007916995,0.09062845,0.2011217,0.0001275174,0.0008445943,0.009606783,0.0003131952,0.01537204,0.595641,0.001686853,0.07667688,0.00006392275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947791,0.001467088,0.0008342712,0.0001259922,0.00003638283,0.0002503995,0.0001867104,0.00004812685,0.002271846],"genre_scores_gemma":[0.9962564,0.0006673202,0.0008721722,0.0001603413,0.00002961861,0.0001598671,0.0005393754,0.00000811187,0.001306968],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002166488,"threshold_uncertainty_score":0.007247627,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02150986609143147,"score_gpt":0.2551986313955497,"score_spread":0.2336887653041182,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}